Autolus Therapeutics AUTL Rebounds 424 as Buyer Interest Emerges Near Key Support Level UiPath Q1 2027 Earnings Transcript Released Key Insights from Automation Leader IHG Q4 2025 Earnings EPS Slightly Misses Estimates Amidst Operational Challenges Oil Supply Disruption Risks in 2026 Five Factors Under Scrutiny